awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38070906-D3469D59-9DA6-4155-B126-2EF8B591A9D6
Q38070906-D3469D59-9DA6-4155-B126-2EF8B591A9D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38070906-D3469D59-9DA6-4155-B126-2EF8B591A9D6
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
P2860
Q38070906-D3469D59-9DA6-4155-B126-2EF8B591A9D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38070906-D3469D59-9DA6-4155-B126-2EF8B591A9D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f30dec96152ab14dc5aafd8f07d7dc012a38c65b
P2860
Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.